Skip to main content
. 2016 Jun 11;6(4):319–328. doi: 10.1016/j.apsb.2016.05.010

Figure 4.

Fig. 4

In vivo whole-body fluorescence imaging in mice administered DiR-loaded formulations via tail vein at 2 h (A), 4 h (B), 8 h (C) and 12 h (D): normal mice treated by DPD-L[DiR] (a), infected mice by DPD-L[DiR] (b), infected mice by mPEG-L[DiR] (c), and normal mice by mPEG-L[DiR] (d).